Amycretin Shows Significant Weight Loss, HbA1c Reductions in Type 2 Diabetes
Amycretin (Novo Nordisk), a unimolecular agonist of glucagon-like peptide 1 (GLP-1) and amylin receptors, induced significant weight loss and hemoglobin A1c (HbA1c) reductions in patients with type 2 diabetes in…